Trademark: 97602903
Word
OVASUITE
Status
Pending
Status Code
653
Status Date
Friday, January 19, 2024
Serial Number
97602903
Mark Type
5000
Filing Date
Thursday, September 22, 2022

Trademark Owner History

Classifications
42 Providing reagent sample testing and diagnostic services for others for scientific research purposes; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; providing medical and scientific research information; providing medical and scientific research information in the field of cancer detection and clinical trials; providing medical and scientific research information in the field of ovarian cancer detection and clinical trials; providing medical and scientific research information in the field of breast cancer detection and clinical trials; providing medical and scientific research services in the field of biomarker testing and cancer screening; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the field of ovarian cancer treatment and diagnosis; medical and scientific research services in the field of breast treatment and diagnosis; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the fields of women's health, genetics, gynecology and cancer; scientific research consulting in the field of genetics; product development in the fields of women's health, genetics, gynecology, diagnostics and cancer; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; consulting services in the fields of laboratory testing and diagnostics; providing a web hosting platform for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; platform as a service (PAAS) featuring computer software platforms for diagnostic testing in the field of women's health; software as a service (SAAS) services featuring software for diagnostic testing; software as a service (SAAS) services featuring software for cancer diagnostic testing; software as a service (SAAS) services featuring software for genetic testing; software as a service (SAAS) services featuring software using artificial intelligence for medical diagnostic testing; providing on-line non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing temporary use of on-line non-downloadable software and applications using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing a website featuring non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing
The mark consists of the term OVASUITE in stylized font.
OVA SUITE; OVER SUITE
Color is not claimed as a feature of the mark.

Trademark Events
Jan 19, 2024
Notification Of Letter Of Suspension E-Mailed
Jan 19, 2024
Letter Of Suspension E-Mailed
Jan 19, 2024
Suspension Letter Written
Dec 22, 2023
Teas/Email Correspondence Entered
Dec 21, 2023
Correspondence Received In Law Office
Dec 21, 2023
Teas Response To Office Action Received
Sep 19, 2023
Application Extension Granted/Receipt Provided
Sep 19, 2023
Application Extension To Response Period - Received
Jun 24, 2023
Notification Of Non-Final Action E-Mailed
Jun 24, 2023
Non-Final Action E-Mailed
Jun 24, 2023
Non-Final Action Written
Jun 22, 2023
Assigned To Examiner
Oct 9, 2022
New Application Office Supplied Data Entered
Sep 26, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24